MSP Starch Products Inc. (MSP), the Canadian innovator behind Solnul® resistant potato starch, announced the selection of LEHVOSS Group as its exclusive distribution partner for the European market. This decision strengthens Solnul®’s commercial footprint across the globe while targeting, one of the world’s largest and fastest-growing gut health markets.
LEHVOSS Group, a fourth-generation family business based in Hamburg, is known for its efficiency, market expertise, and commitment to sustainability. The Nutrition Division focuses on innovative, science-based ingredients and minerals for food supplements, aligned with market trends. As a distributor with deep technical expertise and advanced digital platforms, LEHVOSS is well equipped to communicate Solnul®’s scientific discoveries into clear, market-ready insights for customers – an approach that closely aligns with Solnul®’s science-driven growth strategy.
Interest in resistant starch and the unique type of fibre it offers continues to rise across Europe as brands and consumers are increasingly prioritising gut health while looking for natural solutions like prebiotics, probiotics, and digestive enzymes. Following key commercial milestones, Solnul® is now positioned to meet this demand at scale, which brings this long-awaited, well-tolerated and scientifically backed microbiome solution to the European market.
“Our gut health portfolio is intentionally selective and built around credible, science-backed ingredients,” said Paul Montgomery, Head of Product Management at LEHVOSS Nutrition. “Solnul® strengthens our fibre and whole food ingredients offering.” “We are confident that our LEHVOSS Nutrition Health Platform, combined with the recent integration of our AI product assistant, will empower and educate our customers to seamlessly and efficiently incorporate this outstanding and on-trend ingredient into their products,” added Teresita Rudà, Head of Marketing and Brand Positioning at LEHVOSS Nutrition.
“As demand for fibre continues to grow across Europe, this expansion advances our mission to reunite the microbiome with its favourite food, Solnul®, and to bring the benefits of resistant starch to a broader audience,” said Jason Leibert, Chief Growth Officer at Solnul®. “Today, the average European consumes only around 4 g of the recommended 20 g of resistant starch per day – highlighting how far modern diets have moved away from this foundational fibre.”
Vitafoods Europe, May 2026
Building on its European expansion, Solnul® will engage with industry leaders at Vitafoods Europe 2026, exhibiting at the LEHVOSS Group booth (3C72). On May 6, 2026, Solnul® will take the stage at the Vitafoods Insights Theatre (6H2) as a panelist in the Upcycling and Circularity that Scales discussion. The company will showcase how clinically backed, upcycled ingredients like Solnul® are redefining the standard for branded ingredients in Europe – delivering premium gut health solutions with sustainability built in.
i. Grandview Research Report: Europe Digestive Health Products Market (2024-2030)
ii. Miketinas DC, Shankar K, Maiya M, Patterson MA. Usual Dietary Intake of Resistant Starch in US Adults from NHANES 2015-2016. J Nutr. 2020 Oct 12;150(10):2738-2747. doi: 10.1093/jn/nxaa232. PMID: 32840627.
Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com. Twitter: @Innovfoodtech. Instagram: @innovationsinfoodtechnology. Linkedin: www.linkedin.com/in/terry-prior52
